Evolent Health Affirms FY2026 Sales Guidance of $2.400B-$2.600B vs $2.487B Est.
Benzinga Newsdesk 5 months ago
NewsGuidance
Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.400 billion-$2.600 billion vs $2.487 billion estimate.
Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.400 billion-$2.600 billion vs $2.487 billion estimate.